I don’t believe your out of line in your assessm
Post# of 153767
(Total Views: 528)
Posted On: 09/21/2021 6:52:24 PM
I don’t believe your out of line in your assessment at all. I remember Nader saying that we paid a premium for these Brazil trials to be started and completed in less than 2 to 2 1/2 months. Your timeline matches that with extra time built in for the severe trial. Now you can throw out a similar timeline for the Critical Trial as soon as we get a starting date.
We paid a premium to get results fast and that was money well spent. I would be a little pissed off if we had the very slow Amerex taking a year for these Brazil trials as CRO. I have to give credit to Nader for not using Amerex any longer. They didn’t have the staffing to progress our trials in a timely manner and it was a newly hired Dr. Recknor that sped up the end of our trials phase 2 trials. Now we have a very exciting CRO in Israelite Albert Einstein that is very efficient and who we paid extra to be taken care of in a very short time. They will be timely.
We have to realize that our results are coming sooner than later and that we should with our much improved trial designs meet our primary endpoints. Why you ask? Because we already showed that we can on the severe trial and we know on the critical trial we didn’t make it on half life. That issue is resolved also. We applied what we learned from the phase 2 trials like we were suppose to. Success is coming and we should applaud our management for what they have done.
Hence… good times are just around the corner Normy. Have fun and make that other Critical Trial prediction too… I am all ears.
We paid a premium to get results fast and that was money well spent. I would be a little pissed off if we had the very slow Amerex taking a year for these Brazil trials as CRO. I have to give credit to Nader for not using Amerex any longer. They didn’t have the staffing to progress our trials in a timely manner and it was a newly hired Dr. Recknor that sped up the end of our trials phase 2 trials. Now we have a very exciting CRO in Israelite Albert Einstein that is very efficient and who we paid extra to be taken care of in a very short time. They will be timely.
We have to realize that our results are coming sooner than later and that we should with our much improved trial designs meet our primary endpoints. Why you ask? Because we already showed that we can on the severe trial and we know on the critical trial we didn’t make it on half life. That issue is resolved also. We applied what we learned from the phase 2 trials like we were suppose to. Success is coming and we should applaud our management for what they have done.
Hence… good times are just around the corner Normy. Have fun and make that other Critical Trial prediction too… I am all ears.
(8)
(0)